George Vasmatzis

Years Active: 2018-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Louis Y El Khoury, Wan Hsin Lin, James B Smadbeck, Michael T Barrett, Dorsay Sadeghian, Alexa F McCune, Giannoula Karagouga, John C Cheville, Faye R Harris, Lindsey M Kinsella, Ryan W Feathers, Janet L Schafer Klein, Marina Rs Walther-Antonio, Sarah H Johnson, Alan R Penheiter, Giuseppe Cucinella, Gabriella Schivardi, Aditya Bhagwate, Mitesh J Borad, Aaron S Mansfield, Stephen J Murphy, Andrea Mariani, George Vasmatzis, Panos Z Anastasiadis, Saravut J Weroha, Alyssa M Larish
Epigenomics may begin to explain in vitro differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancer. Epigenomics (2023)
George Vasmatzis, Xue Wang, James B Smadbeck, Stephen J Murphy, Katherine B Geiersbach, Sarah H Johnson, Athanasios G Gaitatzes, Yan W Asmann, Farhad Kosari, Mitesh J Borad, Daniel J Serie, Sarah A McLaughlin, Jennifer M Kachergus, Brian M Necela, E Aubrey Thompson
Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2+ breast cancer samples. BMC cancer 18 (1) (2018)

George Vasmatzis.css-eqlu8i{font-size:small;padding-left:4px;}